| Value | ₹2.49 Cr |
|---|
NSE filing, NSE: NAM-INDIA. Summary written from the filing by ALFA Finder's alert engine.
Nippon Life India Asset Management Ltd: key numbers
- Share price
- ₹922.50
- Market cap
- ₹59,044 Cr
- Revenue (annual)
- ₹2,709 Cr
- Net profit (annual)
- ₹1,529 Cr
- P/E (TTM)
- 36.5×Sector 19.7×
- Promoter holding
- 71.72%-0.08% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nippon Life India Asset Management Ltd
All →Nippon Life India Asset Management Earnings Call Transcript: Key Takeaways
Nippon Life India (NAM India) leads top-10 AMC growth but faced profit compression from a one-time regulatory settlement.
Nippon Life India Asset Management Dividend
Nippon Life India Asset Management Limited declared an interim dividend of ₹9.5 per equity share. The record date for the dividend is October 28, 2026.
Nippon Life India Asset Management Investor Presentation: Key Takeaways
Nippon Life India AMC reported Q2 FY27 Profit After Tax of INR 3.24 bn, maintaining its position as India's 4th largest AMC with a 9.02% market share.
Nippon Life India Asset Management Q2 FY27 Results: Net Profit ₹324.4 Cr, Down 5.9% YoY
Nippon Life India Asset Management Ltd reported revenue from operations of ₹795.8 Cr (+20.9% YoY) and net profit of ₹324.4 Cr (-5.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹324.4 Cr · -5.9% YoY
Nippon Life India Asset Management Other Announcement
Nippon Life India Asset Management Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
Nippon Life India Asset Management Other Announcement
Nippon Life India Asset Management's ESG score was revised to 75.7 from 77 by SES ESG Research. The reduction was attributed to environmental and social parameters.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.